Related Experiment Video

Updated: Feb 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness - California, Kentucky, Michigan, and Utah,

Monique Foster, Sumathi Ramachandran, Katie Myatt

    MMWR. Morbidity and Mortality Weekly Report
    |November 2, 2018
    PubMed

    Insights

    Hepatitis A outbreaks in 2017 primarily affected people who use drugs or are homeless, spreading through direct contact, not contaminated food. Vaccination is key to preventing future outbreaks in these high-risk groups.

    Area of Science:

    • Public Health
    • Infectious Disease Epidemiology
    • Vaccinology

    Background:

    • Acute hepatitis A virus (HAV) infections pose a significant public health concern.
    • Recent HAV outbreaks have largely been linked to contaminated food products.

    Purpose of the Study:

    • To analyze the epidemiology of HAV infections reported in 2017.
    • To identify transmission patterns and at-risk populations for HAV in the United States.

    Main Methods:

    • Retrospective analysis of 1,521 reported acute HAV infections from four US states in 2017.
    • Investigation of transmission routes, including direct person-to-person contact and potential foodborne sources.

    Main Results:

    • The majority of reported HAV infections occurred in individuals reporting drug use (injection or noninjection) or homelessness.
    • Investigations confirmed direct person-to-person transmission as the primary mode of spread, distinct from foodborne outbreaks.
    • Outbreaks signal a shift in HAV epidemiology towards these vulnerable populations.

    Conclusions:

    • Direct person-to-person transmission of HAV is a growing concern, particularly among populations reporting drug use and homelessness.
    • Targeted vaccination strategies for high-risk populations are crucial for preventing future HAV outbreaks.
    • Understanding evolving transmission dynamics is essential for effective public health interventions.

    More Related Videos

    Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

    Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

    Published on: June 5, 2020

    7.9K
    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

    Published on: February 1, 2017

    14.0K

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    244
    Hepatic Drug Excretion: Influencing Factors01:16

    Hepatic Drug Excretion: Influencing Factors

    The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
    581
    Hepatic Drug Clearance: Role of Transporters01:14

    Hepatic Drug Clearance: Role of Transporters

    In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
    309
    Hepatic Drug Excretion: Enterohepatic Cycling01:17

    Hepatic Drug Excretion: Enterohepatic Cycling

    Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
    Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
    2.8K
    Hepatic Drug Clearance: Effect of Protein Binding01:09

    Hepatic Drug Clearance: Effect of Protein Binding

    Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
    For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
    553
    Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

    Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

    Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
    Most drugs undergo restrictive clearance, which is proportional to the...
    515